Does TREPROSTINIL Cause Dementia alzheimer's type? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Dementia alzheimer's type have been filed in association with TREPROSTINIL (TYVASO). This represents 0.0% of all adverse event reports for TREPROSTINIL.
18
Reports of Dementia alzheimer's type with TREPROSTINIL
0.0%
of all TREPROSTINIL reports
2
Deaths
4
Hospitalizations
How Dangerous Is Dementia alzheimer's type From TREPROSTINIL?
Of the 18 reports, 2 (11.1%) resulted in death, 4 (22.2%) required hospitalization.
Is Dementia alzheimer's type Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Dementia alzheimer's type?
RIVASTIGMINE (428)
APIXABAN (362)
ADALIMUMAB (228)
INSULIN GLARGINE (162)
SACUBITRIL\VALSARTAN (158)
LENALIDOMIDE (153)
ETANERCEPT (152)
INSULIN LISPRO (148)
TOFACITINIB (143)
TRIPTORELIN (106)
Which TREPROSTINIL Alternatives Have Lower Dementia alzheimer's type Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE